Table 2.
Clinical and traditional risk factors in patients with and without recurrent CVEs
| Characteristics | With recurrent CVEs (n = 153) | Without recurrent CVEs (n = 2131) | p value |
|---|---|---|---|
| Age, years | 62.58 ± 9.17 | 58.25 ± 10.50 | < 0.001 |
| Male, n (%) | 115 (75.2) | 1559 (73.2) | 0.637 |
| Body mass index, kg/m2 | 25.85 ± 3.09 | 26.39 ± 3.15 | 0.042 |
| BMI < 25 kg/m2 | 70 (45.9) | 718 (33.7) | 0.003 |
| SBP, mmHg | 127 ± 18 | 128 ± 17 | 0.645 |
| SBP < 130 mmHg | 78 (51.2) | 1057 (49.6) | 0.785 |
| DBP, mmHg | 76 ± 10 | 78 ± 16 | 0.130 |
| DBP < 80 mmHg | 72 (47.3) | 889 (41.7) | 0.231 |
| Heart rate, bpm | 71 ± 10 | 71 ± 10 | 0.761 |
| Biochemical parameters | |||
| FBG, mmol/L | 7.12 ± 2.43 | 7.24 ± 2.31 | 0.526 |
| FBG 4.4 ~ 6.5 mmol/L | 60 (38.9) | 886 (41.6) | 0.548 |
| HbA1c, % | 7.53 ± 1.37 | 7.38 ± 1.25 | 0.150 |
| HbA1c < 7.0% | 74 (48.4) | 1072 (50.3) | 0.932 |
| TC, mmol/L | 4.03 ± 1.08 | 4.08 ± 1.19 | 0.618 |
| HDL-C, mmol/L | 0.99 ± 0.26 | 1.01 ± 0.27 | 0.325 |
| LDL-C, mmol/L | 2.44 ± 0.93 | 2.45 ± 0.97 | 0.942 |
| LDL-C < 1.4 mmol/L | 16 (10.6) | 232 (10.9) | 0.907 |
| TG, mmol/L | 1.54 (1.17–2.12) | 1.56 (1.17–2.20) | 0.502 |
| Lp(a), mg/dL | 20.44 (10.01–43.96) | 14.71 (6.43–34.16) | 0.002 |
| ApoAI, g/L | 1.29 ± 0.30 | 1.31 ± 0.30 | 0.407 |
| ApoB, g/L | 0.91 ± 0.30 | 0.92 ± 0.30 | 0.746 |
Continuous values are summarized as mean ± SD, median (Q1–Q3) and categorical variables as n (percentage)
CVEs cardiovascular events, SBP systolic blood pressure, DBP diastolic blood pressure, FBG fasting blood glucose, HbA1c glycosylated hemoglobin, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, TG triglyceride, Lp(a) lipoprotein(a), ApoAI apolipoprotein AI, ApoB apolipoprotein B